CN1103782A - 眼局部给药的抗变态反应的药物组合物 - Google Patents

眼局部给药的抗变态反应的药物组合物 Download PDF

Info

Publication number
CN1103782A
CN1103782A CN94105811A CN94105811A CN1103782A CN 1103782 A CN1103782 A CN 1103782A CN 94105811 A CN94105811 A CN 94105811A CN 94105811 A CN94105811 A CN 94105811A CN 1103782 A CN1103782 A CN 1103782A
Authority
CN
China
Prior art keywords
pharmaceutical composition
antiallergic
eye drops
ige antibody
antiallergic pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94105811A
Other languages
English (en)
Chinese (zh)
Inventor
大森齐
小河贵裕
德持史纪
奥村敦司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of CN1103782A publication Critical patent/CN1103782A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN94105811A 1993-05-14 1994-05-13 眼局部给药的抗变态反应的药物组合物 Pending CN1103782A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11279593 1993-05-14
JP112795/93 1993-05-14

Publications (1)

Publication Number Publication Date
CN1103782A true CN1103782A (zh) 1995-06-21

Family

ID=14595714

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94105811A Pending CN1103782A (zh) 1993-05-14 1994-05-13 眼局部给药的抗变态反应的药物组合物

Country Status (11)

Country Link
US (1) US5475033A (enExample)
EP (1) EP0624367A1 (enExample)
KR (1) KR0160538B1 (enExample)
CN (1) CN1103782A (enExample)
AU (1) AU679043B2 (enExample)
BR (1) BR9401965A (enExample)
CA (1) CA2123367C (enExample)
HU (1) HUT70749A (enExample)
PL (1) PL175375B1 (enExample)
RU (1) RU2107497C1 (enExample)
TW (1) TW264385B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886045A (en) * 1995-04-24 1999-03-23 Taiyo Pharmaceutical Co., Ltd. Remedy for allergic diseases in the region of the nose
RU2123840C1 (ru) * 1996-05-27 1998-12-27 Петросян Вилен Гургенович Капли петросяна n 1a (n 2a - n 7a их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
RU2123327C1 (ru) * 1996-05-27 1998-12-20 Вилен Гургенович Петросян Капли петросяна n 1 (n 2 - n 7 их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
RU2123839C1 (ru) * 1996-05-27 1998-12-27 Вилен Гургенович Петросян Капли петросяна n 1б (2б-7б их варианты) для лечения аллергических и неатопических заболеваний глаз и носа
AU734793B2 (en) * 1998-11-05 2001-06-21 Taiho Pharmaceutical Co., Ltd. Therapeutic Drug for the treatment of micturition disorders
TWI241289B (en) * 2001-04-16 2005-10-11 Taiho Pharmaceutical Co Ltd Suplatast tosilate crystals
CA2445269A1 (en) * 2001-05-03 2002-11-14 Novartis Ag Anti-ige antibody to treat ocular allergies
RU2238088C1 (ru) * 2003-10-02 2004-10-20 Государственное предприятие Институт иммунологии Федерального управления медико-биологических и экстремальных проблем при Министерстве здравоохранения РФ N, n-диэтилдитиокарбаминовой кислоты натриевая соль, обладающая противоаллергическим действием
WO2010141883A1 (en) * 2009-06-04 2010-12-09 The Regents Of The University Of Colorado Compounds that modulate autoimmunity and methods of using the same
WO2012162697A1 (en) 2011-05-26 2012-11-29 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
SG11201408230VA (en) 2012-06-11 2015-01-29 Macuclear Inc Therapeutic formulation and methods of treatment
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
US9820957B2 (en) 2016-03-24 2017-11-21 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmunity
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523976B1 (fr) * 1982-03-26 1985-08-30 Pasteur Institut Nouveau produit proteique, obtention et application comme medicament, en particulier immunoregulateur et antiallergique
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
US4691018A (en) * 1985-05-23 1987-09-01 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives and their use as anti-allergic agents
US5157052A (en) * 1990-12-27 1992-10-20 Monsanto Company Method for inhibiting ige production
EP1587143A1 (en) * 1991-01-22 2005-10-19 Nec Corporation Resin sealed semiconductor integrated circuit

Also Published As

Publication number Publication date
KR0160538B1 (ko) 1998-12-01
BR9401965A (pt) 1994-12-13
US5475033A (en) 1995-12-12
AU6193494A (en) 1994-11-17
CA2123367A1 (en) 1994-11-15
AU679043B2 (en) 1997-06-19
TW264385B (enExample) 1995-12-01
EP0624367A1 (en) 1994-11-17
HU9401434D0 (en) 1994-08-29
PL175375B1 (pl) 1998-12-31
CA2123367C (en) 1998-04-14
RU94016184A (ru) 1996-05-20
HUT70749A (en) 1995-10-30
RU2107497C1 (ru) 1998-03-27

Similar Documents

Publication Publication Date Title
CN1103782A (zh) 眼局部给药的抗变态反应的药物组合物
CN1128789C (zh) 苯并环庚并噻吩化合物
CN1311675A (zh) 具有lgE影响性能的化合物
CN1520290A (zh) 含铜胺氧化酶的碳环肼基抑制剂
CN1671391A (zh) 用于缓解疼痛的新方法及组合物
CN1617868A (zh) 作为EP2－受体激动剂的ω－环烷基17－杂芳基前列腺素E2 类似物
CN101068536A (zh) S1p受体激动剂的剂量方案
CN1189175C (zh) 用于预防和治疗原虫病的组合物和方法
CN1252722A (zh) 脱羰乙氧氯雷他定在治疗尿失禁、晕动病和眩晕药剂的制备中的应用
JP2746832B2 (ja) 眼局所抗アレルギー剤
CN1956978A (zh) 作为肥大细胞类胰蛋白酶抑制剂的[4－(5－氨基甲基－2－氟－苯基) －哌啶－1－基] －(4－溴－3－甲基－5－丙氧基－噻吩－2－基)-甲酮盐酸盐
CN1151695A (zh) 含苯甲酰胺的医药组合物
CN1270707C (zh) 滴眼液
CN1137793A (zh) 用作α2肾上腺素能受体兴奋剂的6-(2-咪唑啉基氨基)喹啉化合物
CN1564683A (zh) 抗炎类固醇和muc－1促分泌素结合治疗干眼病的方法
CN1126545C (zh) 眼科用制剂
CN1073552C (zh) 用于神经变性疾病治疗的苯甲酰胺类化合物
CN1124842C (zh) 缓释滴眼剂
CN1819822A (zh) 含有取代喹啉和取代二苯砜的组合物以及使用方法
CN1859846A (zh) 白屈菜赤碱、其类似物及其在治疗躁郁症和其他认知紊乱中的应用
JP2007529545A (ja) ダウン症候群の治療法
CN1293880C (zh) 水性液体制剂和光稳定的水性液体制剂
CN1108095A (zh) 用于预防和治疗近视的组合物
CN1753677A (zh) 降眼压剂
CN101052403A (zh) 提高5,5－二苯基巴比妥酸的生物利用度和增强其脑递送的组合物及方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned